Skip to main content
OpenTrials

Clinical trial condition

Metastatic Castration Resistant Prostate Cancer

Explore clinical trials studying Metastatic Castration Resistant Prostate Cancer. Study availability and eligibility vary by location and protocol.

36 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Castration Resistant Prostate Cancer trial results

Active, not recruiting

A Study of CHeckpoint Inhibitors in Men With prOgressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 Inactivation

NCT04104893

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
Locations
  • San Francisco VA Medical Center, San Francisco, CA San Francisco, California, United States
  • VA Greater Los Angeles Healthcare System, West Los Angeles, CA West Los Angeles, California, United States
  • Washington DC VA Medical Center, Washington, DC Washington D.C., District of Columbia, United States
  • Bay Pines VA Healthcare System, Pay Pines, FL Bay Pines, Florida, United States
View all 13 locations
View Trial Details
Completed

A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency

NCT02975934

Conditions
Metastatic Castration Resistant Prostate Cancer
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic - Arizona Phoenix, Arizona, United States
  • Arizona Oncology Associates - USOR Tucson, Arizona, United States
  • University of Southern California Beverly Hills, California, United States
View all 150 locations
View Trial Details
Completed

Immunotherapy in Patients With Metastatic Cancers and CDK12 Mutations

NCT03570619

Conditions
Metastatic Cancer, Metastatic Castration Resistant Prostate Cancer, Neoplasm Metastasis, +5 more
Locations
  • University of California San Diego, Moores Cancer Center San Diego, California, United States
  • University of California San Francisco/Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • H. Lee. Moffitt Cancer Center & Research Institute, Inc. Tampa, Florida, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
View Trial Details
Completed

A Study to Assess the Benefit of Treatment Beyond Progression With Enzalutamide in Men Who Are Starting Treatment With Docetaxel After Worsening of Their Prostate Cancer When Taking Enzalutamide Alone

NCT02288247

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +12 more
Locations
  • Site AT43004 Linz, Austria
  • Site AT43001 Vienna, Austria
  • Site BE32003 Bonheiden, Belgium
  • Site BE32002 Liège, Belgium
View all 89 locations
View Trial Details

Related conditions